Investment Trusts

Target Healthcare REIT plc

THRL:LSE

Target Healthcare REIT plc

Actions
  • Price (GBX)110.40
  • Today's Change-0.20 / -0.18%
  • Shares traded1.64m
  • 1 Year change-6.04%
  • Beta0.3468
Data delayed at least 20 minutes, as of Mar 02 2021 17:07 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Total returns on £1000

1Y
Fund/benchmarkChange
PriceTarget Healthcare REIT plc (Ordinary Share)-0.57%
NAVTarget Healthcare REIT plc (Ordinary Share)+6.75%
Morningstar's BenchmarkFTSE EPRA Nareit UK TR GBP--

Key statistics

On Tuesday, Target Healthcare REIT plc (THRL:LSE) closed at 110.40, -8.76% below its 52-week high of 121.00, set on Mar 05, 2020.
52-week range
Today
65.58Mar 18 2020121.00Mar 05 2020
Markit short selling activity
Low
Med
High
Shares outstanding457.49m
Market cap486.95m GBP
Total assets540.48m GBP
Total expense ratio1.51%
High112.40
Low110.40
Previous close110.60
Average volume558.23k
YTD Change-3.16%
Beta0.3468%
Diluted NAV (est)106.52
Diluted NAV (last pub)108.20
Premium/Discount+3.64%
Gearing+15.25%
Annual div (ADY)6.70
GBX
Annual div yield (ADY)6.06%
Div ex-dateFeb 11 2021
Div pay-dateFeb 26 2021
Data delayed at least 20 minutes, as of Mar 02 2021 17:07 GMT.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.